Palliative high-dose-rate endobronchial brachytherapy for recurrent carcinoma: the University of Louisville experience.

Abstract

PURPOSE To determine the efficacy and toxicity of iridium-192 high-dose-rate (HDR) endobronchial brachytherapy (EBBT) for symptomatic palliation of respiratory symptoms caused by endobronchial carcinoma. METHODS We reviewed the treatment outcomes of 52 patients with carcinoma who underwent HDR EBBT between July 1995 and July 2005 for recurrent tumors at… (More)
DOI: 10.1089/jpm.2009.0411

Topics

Cite this paper

@article{Guarnaschelli2010PalliativeHE, title={Palliative high-dose-rate endobronchial brachytherapy for recurrent carcinoma: the University of Louisville experience.}, author={Jessica N Guarnaschelli and Bobby Jose}, journal={Journal of palliative medicine}, year={2010}, volume={13 8}, pages={981-9} }